Similarly, in astrocytes most MS drugs discussed here affect the expression of pro-inflammatory and anti-inflammatory factors that is dependent on NFκB-induced transcriptional programs (Figure 3A). This evidence concerns the gene NFKB1 and myeloid sarcoma.